As the baby boomers age, the number of adults who suffer from frequent falls, gait disorders, cognitive impairment, dementia and other neurological diseases continues to grow exponentially. New approaches are needed to prevent the anticipated epidemic from overwhelming health care systems and to enhance quality of life in aging populations.
To improve the treatment of age-related movement, cognition and mobility disorders and to alleviate the burden associated with them.
We leverage a combination of clinical, engineering and neuroscience expertise:
- To gain new understandings of the mechanisms that contribute to cognitive and motor function and their changes with aging and disease.
- To develop new methods and tools for early detection and tracking of cognitive and motor decline.
- To develop novel methods for prevention and treatment.
Researchers at CMCM collaborate with scientists across the globe. These include, for example, investigators at Harvard Medical School, Rush University, University of Illinois, Columbia University, Mount Sinai Medical School, University of Bologna, Newcastle University, University of Leuven, University of Sassari, University Medical Centre St Radboud, and University of Genoa.